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Intracardiac thrombus is an important clinical condition because of its potential complica-
tions. Detection of ventricular thrombi is generally performed by transthoracic echocardio-
graphy while atrial thrombi are generally evaluated by transesophageal echocardiography.
Contrast-enhanced computerized tomography is more sensitive for detecting ventricular
and atrial thrombi than transthoracic echocardiography, but the technique has been
demonstrated to be inferior to transesophageal echocardiography for displaying atrial
thrombi. Cardiac magnetic resonance imaging provides superior specificity for evaluation
of tissue characteristics and helps to differentiate thrombi from other masses.
& 2013 The Czech Society of Cardiology. Published by Elsevier Urban & Partner Sp.z o.o. All
rights reserved.
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Transesophageal echocardiography (TEE) is considered to be
superior to the transthoracic echocardiography (TTE) for
detecting cardiovascular sources of embolism although the
latter remains the cornerstone of noninvasive cardiac ima-
ging. Imaging by means of TEE, a semi-invasive procedure, is
performed within the esophagus and the gastric fundus. TEE
has high sensitivity and specificity for examination of thech Society of Cardiology.
t, 45/14, 06460 Cankaya, A
o.com.tr, ozgurula@hotmposterior and inferior heart territories because of their
adjacency to the esophagus and stomach. The lack of inter-
vening lung and bone, and the use of higher-frequency
imaging transducers provide enhanced spatial resolution
and improved detection of intracardiac thrombi and sponta-
neous left atrial echo contrast, a marker of blood stasis [1].
Clinical detection of ventricular thrombi is generally
performed by TTE and evaluation of atrial thrombi is gen-
erally performed by TEE. Limitation of TEE is the difficulty toPublished by Elsevier Urban & Partner Sp.z o.o. All rights reserved.
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c o r e t v a s a 5 5 ( 2 0 1 3 ) e 1 7 6 – e 1 8 3 e177view some regions such as the left ventricular apex, distal
ascending aorta, and proximal aortic arch. Image acquisition
is limited in these areas, and other imaging modalities should
be considered, e.g. helical computed tomography (CT) and
cardiovascular magnetic resonance (CMR) imaging. In addi-
tion, TEE may lead to some complications which are essen-
tially associated with esophageal intubation. These include
trauma to the oropharynx, esophagus, and stomach giving
rise to odynophagia, esophageal perforation, and upper
gastrointestinal bleeding [2]. Therefore, the main contraindi-
cations of TEE are oropharyngeal pathology, esophageal
stricture, varices, and recent upper gastrointestinal bleeding.2. Left atrial thrombus
Predisposing factors for left atrial (LA) thrombus are mitral valve
pathology, prosthetic mitral valve, poor left ventricular function,
and abnormal LA contractile function, such as atrial fibrillation
(AF). Enlarged and bifid left atrial appendage (LAA) is among the
structural or anatomical risk factors. The left atrium can be
visualized on two-dimensional TTE from all of the standard
imaging windows. Image of the thrombi in the LA resembles
intracavitary masses. The density of thrombus differs from the
surrounding tissue. The thrombi usually have smooth contours
and move synchronously with adjacent heart wall during the
heart cycle. Scanning at least two or more different views is
warranted for accurate diagnosis of thrombus. Sometimes,
thrombi are visualized as an echolucent structure and are
difficult to be described. In such cases, the diagnosis may be
confirmed by the use of intravenous echo-contrast agent to
improve the discrimination between blood and intracavitary
masses [3]. Contrast echocardiography is a technique to improve
endocardial border delineation and provides real time assess-
ment of intracardiac blood flow. Unless thrombi are very large
and spreading to the body of the left atrium, they are hardly
identified by means of TTE because the left atrium lies in the far
field of the interrogating ultrasound beam. Often they reside
between the trabeculae of the LAA. The ability of TTE to identify
or exclude LA or left atrial appendage thrombi is limited, with a
reported sensitivity of 40–60%, due largely to poor visualization
of the LAA [4]. In contrast, TEE provides detailed visualization of
the body of LA and LAA from multiple imaging planes, so offers
superior assessment. It is the current gold standard diagnostic
method. In one intraoperative study, the sensitivity and speci-
ficity of TEE for left atrial thrombi detection (in patients among
whom the left atrium was directly examined at surgery) are
93–100% and 99–100%, respectively [4]. Anecdotal reports sug-
gest that three-dimensional (3D) TEE is also excellent, but no
large comparative study has been reported. The ability to
exclude LAA thrombi that are ‘‘suspected’’ by two-dimensional
TEE is also another advantage of 3D TEE. The superiority of the
3D TEE for left atrial appendage analysis lies in the ability to
differentiate the normal trabeculations of the ‘‘rough’’ area of
the appendage from thrombi [5].
Left atrial thrombi are often multiple and vary in size and,
although fasten on the atrial wall, they usually move inde-
pendently to some extent (Fig. 1A and B). Small thrombi must
be distinguished from the normal trabeculations of the LAA
(pectinate muscles), and it may be difficult to distinguishlarger thrombus from tumor. Myxoma is the most commonly
encountered tumor in the left atrium. Myxomas are clinically
important because one-half present with thromboembolism,
which is thought to be the result of embolization of tumor
material itself or of overlying thrombi. These benign tumors
most commonly arise from the inferior limb of the fossa
ovalis. The echocardiographic appearance of the left atrial
tumor may resemble myxoma (especially if the tumor is
encapsulated). Careful inspection of the tumor also demon-
strates the stalk of attachment at its typical location along
the interatrial septum. Both TTE and TEE are highly sensitive
in detecting myxomas. Anatomical details provided by TEE,
such as the site of attachment, may help to differentiate
these tumors from the thrombi. Contrast echocardiography
has been proposed to diagnose thrombi and distinguish the
thrombi from tumors. Most of the malignant tumors have
abnormal neovascularization, with high blood supplies,
which explains why these tumors present an enhancement
of mass by contrast agent. Myxomas have poor blood sup-
plies, with partial enhancement by contrast agent. Conver-
sely, thrombi are avascular, with no enhancement. Contrast
echocardiography is more confidential than conventional
echocardiography for the detection of thrombi [6].
The scene of spontaneous echo contrast (SEC) or ‘‘smoke-
like’’ echo, which indicates the predisposing stasis, almost
always accompanies thrombus and may be helpful in the
differentiation of thrombi from tumor or normal anatomy.
SEC is more likely to be detected by using a high-frequency
ultrasonic transducer (45 MHz, as used in TEE) and high gain
settings (Fig. 2). There is a very strong association between left
atrial spontaneous echo contrast and left atrial thrombi.
Spontaneous echo contrast is believed to be a reflection of
erythrocyte aggregation in low shear rate conditions. SEC has
also been associated with elevated plasma fibrinogen concen-
tration, which reinforces red cell rouleaux formation by elim-
inating the normal electrostatic forces of red blood cells that
result from their negative surface charge [7]. Although most
widely studied in the left atrium and LAA, SEC may also occur
in the right atrium. Spontaneous echo contrast is seen in
patients especially among those with AF or left atrial enlarge-
ment. SEC may be seen in patients with sinus rhythm.
Spontaneous echo contrast is encountered in almost 80% of
the patients with AFand left atrial thrombi. Mitral regurgitation
appears to lessen the frequency of spontaneous echo contrast.
The left atrial appendage is the most frequent site of
thrombus formation in the LA (Fig. 3A and B). Thrombus has
a tendency to be formed in the dysfunctional left atrial
appendage perhaps because of its shape and the presence
of trabeculations. LAA is sometimes seen in the parasternal
short axis through the cardiac base and the apical two
chamber view. However, LAA is best evaluated by TEE. The
widespread use of this high resolution technique has sug-
gested that clinically significant thrombi are commonly
sequestered in this structure; these thrombi are rarely seen
with transthoracic imaging. The LAA is evaluated at the mid-
esophageal level. This technique involves rotation of the TEE
transducer between 01 and 1501 along the LAA axis [3].
The ability to estimate blood flow velocity in the left
or right atrium and left and right atrial appendages
offers a more quantifiable measure of stasis. LAA mechanical
Fig. 1 – (A) and (B) Transesophageal echocardiography of two different patients with left atrial thrombus. Prosthetic mitral
valve is also seen in this figure. Arrows indicate thrombi.
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Doppler measurement of LAA emptying and filling velocities.
The velocity of blood flow at the orifice of the LAA can be
sampled by using pulse-wave Doppler, with a low Nyquist
limit and low wall-filter settings. The pulsed wave Doppler
sample volume should be placed 1 cm inside LAA at trans-
ducer angles between 451 and 1201. It reveals a characteristic
pattern that is dependent upon the patient’s underlying
rhythm and atrial function. In patients with sinus rhythm,
there are well-defined filling and emptying waves (peak
emptying velocity 455 cm/s), appropriately timed with atrial
contraction. However, among patients with atrial fibrillation,
some have well-defined wave forms while others have low
velocity, poorly defined wave forms. A low appendage blood
flow velocity is associated with the presence of appendage
thrombus and denser SEC [8,9]. Thrombogenic risk raiseswith decreasing LAA velocity. The risk of stroke increases
sharply with marked reductions in blood flow velocity
(o15 cm/s), particularly in the left atrial appendage or poster-
ior left atrium [10]. Above a threshold LAA velocity greater
than 55 cm/s, thrombus was ruled out because this velocity
has a negative predictive value of 100% [3].3. Left ventricular thrombus
Left ventricular thrombus is one of the most common
complications of myocardial infarction. Such thrombus is
clinically significant because it may lead to embolic compli-
cations, including stroke. LV thrombus is most often seen
among patients with extensive anterior ST elevation myocar-
dial infarction complicated with anteroapical aneurysm
Fig. 2 – Mid-esophageal four-chamber view of the left atrium (LA), left ventricle (LV), right ventricle (RV), and calcified mitral
valve. Swirling spontaneous echocontrast (or smoke) is detected by TEE in a patient with mitral stenosis.
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stasis and thrombus formation. LV thrombus is seen more
commonly in patients with dilated ventricles [3]. Conversely,
inferior myocardial infarction, successful reperfusion, and
preserved global LV systolic function are associated with a
lower incidence of LV thrombus [11]. Echocardiographic
indices that correlate with LV thrombosis are low ejection
fraction (less than 40%), high LV wall motion score indices,
and high E/Em ratio [3].
Diagnosis of ventricular thrombus include some key fea-
tures. Left ventricular thrombi are usually located in the apical
region and lack any infiltration into the ventricular wall (in
contrast with the left ventricular masses) (Fig. 4). Morphologi-
cally thrombi may be laminar or protruding, with a smooth or
irregular shape. They are usually contiguous with the zones of
noncontracting myocardium. The TTE appearance of LV throm-
bus is variable, and depends upon its age. Recent or actively
forming thrombus may appear echo-lucent, and is highly
mobile and disposed to protrude into the center of the ven-
tricular cavity. Older thrombus generally has smooth cavitary
surface and texture resembling the ultrasound appearance of
hepatic tissue. Patients with subacute, protruding, echo-lucent,
and mobile thrombi are at higher risk of embolic events,
compared with those presented with sessile, laminated, and
organized thrombi [12]. Thrombus usually has higher echogeni-
city than the adjacent myocardium and an increase in echo-
genicity is expected as organization of the thrombus occurs,
although this can vary among patients. The sensitivity of TTE
for the detection of LV thrombus may be suboptimal due to
poor image quality and the difficulty in differentiation of
thrombus from normal trabeculations. In patients with sub-
optimal acoustic windows or prominent LVapical muscle bands
and trabeculations which confound the recognition of throm-
bus, many experts recommend the use of intravenous contrast
agents to enhance the visibility of LV apex to improve the
sensitivity and specificity of thrombus detection by TTE [13,14].LV thrombus appears as a filling defect separated from the
myocardium by contrast, while SEC or the muscular structures
are hidden.
Imaging of the left ventricular apex is difficult by TEE.
Because thrombus is often located in the LV apex, it should be
suspected when an akinetic cardiac apex is thickened and
rounded. A foreshortened image of the LV apex can be
minimized by retroflexing the tip of the TEE probe. A deep
transgastric view (0–201) may provide better resolution because
it is within the near field of the transducer. To distinguish
thrombi from artifacts, it is necessary to acquire optimal
images in at least two different views, throughout the cardiac
cycle. Some laminated thrombi may be difficult to visualize
clearly, and endocardial border delineation may be improved
by a higher transducer frequency (45 MHz) and contrast
echocardiography [3]. Thrombi are more common at the left
ventricular apex, in aneurysms, pseudoaneurysms and deep
recesses, or between the trabeculations in which intertrabe-
cular flow can be demonstrated with color-flow Doppler and
contrast-enhanced echocardiography. An extracardiac mass
that compresses the cardiac structures needs to be differen-
tiated from an intracardiac mass. Extracardiac masses which
may occasionally be visualized by echocardiography include
mediastinal tumors, large hematomas, lung tumors, coronary
aneurysms or fistulas, and pseudoaneurysms.
Three-dimensional (3D) echocardiography has been
demonstrated to be potentially superior to 2D technique in
assessing intracardiac mass as it acquires a pyramidal volume
of information that can be visualized from different angles,
but 3D echocardiography is unavailable in most centers [15].4. Thrombus in the right heart
Thrombus formation is less common in the right atrium
compared with the left atrium. Right heart thrombi are most
Fig. 3 – (A) and (B) Mid-esophageal views of the left atrium (LA) and left atrial appendage (LAA). Arrows indicate thrombus in
the left atrial appendage (LAA). Spontaneous echo contrast (SEC) or ‘‘smoke-like’’ echoes are also depicted in (A).
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source [16]. They may become entrapped in the tricuspid
valve apparatus or right ventricular (RV) trabeculations.
In situ thrombosis in the right heart is usually iatrogenic.
Foreign bodies such as indwelling vascular catheters, pace-
maker leads, and a prosthetic tricuspid valve are predispos-
ing factors [17–19]. Conditions such as RV infarction or
arrhythmogenic RV cardiomyopathy which cause RV dilata-
tion and systolic dysfunction are the rare causes of throm-
bosis [3]. Particularly, in a patient with right heart thrombus
Behc-et’s disease should be under consideration.
Thrombi also may be formed in the RA and the right atrial
appendage among patients with atrial fibrillation or hyper-
coagulable states. In contrast to the LAA, the right atrial
appendage is broad-based and less distinct in appearance.The pectinate muscles extend toward the tricuspid valve and
are not confined to the appendage. The shallow anatomy of
the right atrial appendage makes it a less likely site for
thrombus formation. Thrombus occurs in 3–6% and 15–20%
in right atrial appendage and left atrial appendage respec-
tively among patients with AF [8]. The majority of patients
with right atrial thrombi also have left atrial thrombi.
Thrombi in the right heart may become infected or cause
pulmonary embolism. TTE and TEE may demonstrate RV
dysfunction, tricuspid regurgitation, and leftward atrial septal
bowing in patients with pulmonary thromboemboli. However,
direct visualization of the thrombus located in the pulmonary
arteries or entrapped in the right atrium can rarely be possible.
Comparing the sensitivity, specificity, and the accuracy of
TTE and TEE for diagnosis of the thrombi located in right atrium
Fig. 4 – LV apical thrombus is depicted by apical 2 chamber view of transthoracic echocardiography.
Fig. 5 – Deep transgastric view of the right ventricle (RV). The arrow indicates thrombus in the RV.
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of data. However, the right atrial appendage is rarely seen by
TTE. In contrast right atrial or right atrial appendage thrombi
are easily visualized by TEE. Images of the thrombi in the right
atrium (RA) may be obtained from the mid-esophageal four-
chamber or bicaval views between 01 and 901 on multiplane
TEE. They should be differentiated from an eustachian valve or
a Chiari network, which are the remnants of the right sinus
venosus adjacent to the inferior vena cava. The former is
mostly seen as a thin, mobile, and linear structure, whereas
Chiari network is a large and fenestrated framework extending
across the RAwith additional attachments to its upper wall and
the atrial septum [20]. Unlike thrombi, these structures do not
cross the tricuspid valve during diastole. In the RV, thrombusmay be seen in mid-esophageal four-chamber view and in
transgastric RV inflow view between 801 and 1101 [3] (Fig. 5).
Tumors of the right atrium are unusual, and tend to
become large before the onset of symptoms. The most
common primary benign cardiac neoplasm is myxoma [21].
Larger thrombus may be difficult to distinguish from the
mass. A far more common cause of tumor within the right
atrium is the extension of an intraabdominal tumor, espe-
cially hepatoma or renal cell carcinoma, which may directly
invade the inferior vena cava and extend into the right heart.
Right atrial tumors can be visualized with TTE from subcostal
windows. However, TEE, especially with the longitudinal
bicaval view, can better elucidate the tumor arising from
the inferior vena cava to the right atrium [22,23].
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Although echocardiography and CT are often sufficient for
the evaluation of cardiac and paracardiac masses, CMR
imaging can provide useful information in many cases [24].
Obesity, limited inter-rib spaces, and pulmonary diseases
restrict the ability of TTE to obtain satisfactory images of
the heart chambers. Echocardiography is an excellent
method for evaluation of left-sided structures but is less
accurate for the right side of the heart, paracardiac region,
lungs, and the mediastinum. CMR imaging demonstrates the
localization of cardiac masses and also provides information
on the extension of a tumor. Additionally, CMR imaging
permits increased specificity for evaluation of the tissue
characteristics such as hemorrhage, calcification and cystic
necrosis which are commonly present in the stroma of these
tumors and help to differentiate tumors from thrombi.
Thrombus located in the LV apical aneurysm is demonstrated
in Fig. 6. CMR imaging confirms the diagnosis through the
addition of contrast material, which helps to distinguish the
tumor from the myocardium, thrombus and blood flow
artifacts [25]. Preoperative differentiation of intracardiac
myxoma and thrombus may be difficult. Clinical symptoms,
if present, may be similar, especially with respect to intra-
cardiac obstruction and peripheral embolization. In addition,
atrial thrombi frequently mimic echocardiographic charac-
teristics of atrial myxoma and it is difficult to distinguish
accurately. Hypointensity on T1-weighted images and hyper-
intensity on T2-weighted images relative to the myocardium,
suggestive of tissue with high extracellular water content, are
features commonly observed in myxoma [26]. In addition,
myxomas typically have heterogeneous appearance in MRI,
both before and after contrast administration, due to areas of
necrosis or hemorrhage. Atrial thrombi typically have a
brighter appearance than tumor or myocardium in
inversion-recovery imaging with short inversion times and
a darker appearance with long inversion times. Some
thrombi show delayed contrast enhancement, which char-
acterizes them as organized clots. However, care must beFig. 6 – MR view of thrombus located in LV apical aneurysm.
With permission of Tuncay Hazirolan from Hacettepe
University Department of Radiology.taken to use thin sections for the detection of small thrombi,
and the entire region of interest must be included in the
imaging volume. Along with cine and T2-weighted images,
the standard perfusion and myocardial delayed enhancement
sequences may be very helpful for evaluation of the contrast
enhancement characteristics of cardiac masses. Because they
are avascular, thrombi do not show contrast uptake on
perfusion sequences and usually appear as dark foci border-
ing the endocardium. The delayed enhancement sequence is
the most sensitive sequence for depiction of the thrombus.
Thrombus usually appears as a dark intracavitary or mural
filling defect and is often attached to a center of hyperen-
hanced, infarcted myocardium [27]. Preliminary data suggest
that myocardial delayed-enhancement magnetic resonance
imaging is more accurate in detecting LV thrombus than TTE
[28]. Although atrial thrombus can be detected by contrast
and noncontrast CMR techniques, diagnostic accuracy is
limited compared to TEE [29]. In a study of 24 patients, CMR
imaging was more sensitive than TEE in detecting intracar-
diac thrombi [30]. Data suggest that for patients with
ischemic heart disease, CMR is superior to both TEE and
TTE for diagnosis of intraventricular thrombi. In the study by
Srichai and colleagues, the sensitivity and specificity of CMR
for the diagnosis of ventricular thrombus was compared with
TTE and TEE in 361 patients with ischemic heart disease
scheduled for ventricular reconstructive surgery. Of these,
160 patients underwent all three studies within 30 days of
surgical/pathologic confirmation. The authors determined
that CMR was significantly more sensitive and specific (88%
and 99%, respectively) than TTE (23% and 96%, respectively)
or TEE (40% and 96%, respectively) [31].6. Cardiac computerized tomography
CT has emerged as a potential rival to CMR and echocardio-
graphy. Like CMR, CT has the capability to obtain high-
resolution thin section images and can be gated to the
cardiac cycle to allow cinematic displays of cardiac motion,
although with a lower temporal resolution than CMR. It is
more sensitive than CMR imaging for the detection of
calcification, which represents an often referred advantage
relative to CMR. Current multislice CT scanners allow multi-
planar reconstructions using isotropic voxels, resulting in
high-resolution imaging in virtually any plane. CT requires
the use of ionizing radiation, and gated CT examinations may
result in a radiation dose that exceeds that of cardiac
catheterization. It usually requires the administration of
iodinated contrast, with the attendant risks of nephrotoxicity
and potential allergic reactions. Its utility in tissue character-
ization is inferior to MRI [27]. Contrast-enhanced CT is more
sensitive for detecting ventricular and atrial thrombi than
TTE, but the technique has been demonstrated to be inferior
to TEE for displaying atrial thrombi [32].
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